Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity

Seidai Sato, Shintaro Shinohara, Shinya Hayashi, +13

Respiratory Research

Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice

Masami Kishi, Yoshinori Aono, Seidai Sato, +10

PLoS ONE

Antifibrotic TherapyInflammatory Lung DiseaseLung InflammationImmunologyPulmonary Alveolar Proteinosis +15

Clinical features and outcome of acute exacerbation of interstitial pneumonia associated with connective tissue disease.

Yuko Toyoda, Masaki Hanibuchi, Jun Kishi, +8

The Journal of Medical Investigation

Acute Lung InjuryInflammatory Lung DiseaseAdvanced Lung DiseaseImmunologyClinical Features +15

The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice

Hiroyasu Okazaki, Seidai Sato, Kazuya Koyama, +14

Experimental Lung Research

Bestatin, an inhibitor for aminopeptidases, modulates the production of cytokines and chemokines by activated monocytes and macrophages

Battur Lkhagvaa, Kenji Tani, Keiko Sato, +3

Cytokine

InflammationCytokineAutoimmune DiseaseImmune RegulationImmunology +7

A Patient with Idiopathic Pleuroparenchymal Fibroelastosis Showing a Sustained Pulmonary Function due to Treatment with Pirfenidone

Seidai Sato, Masaki Hanibuchi, Mikiko Takahashi, +5

Internal Medicine

Volume LossAntifibrotic TherapyBody Weight LossAdvanced Lung DiseaseIdiopathic Pleuroparenchymal Fibroelastosis +7

Thymidine Phosphorylase Regulates the Expression of CXCL10 in Rheumatoid Arthritis Fibroblast‐like Synoviocytes

Yuko Toyoda, Sho Tabata, Jun Kishi, +13

Arthritis & Rheumatology

Clinical features of interstitial pneumonia associated with systemic lupus erythematosus

Yuko Toyoda, Kazuya Koyama, Hiroshi Kawano, +10

Respiratory Investigation

RheumatologyClinical FindingAutoimmune DiseaseSystemic Lupus ErythematosusLupus +3

A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease

Masaki Hanibuchi, Soji Kakiuchi, Shinji Atagi, +12

Lung Cancer

Phase Ii TrialMedicineImmunologyPathologyImmune Checkpoint Inhibitor +4

The Tyrosine Kinase Inhibitor TAS-115 Attenuates Bleomycin-induced Lung Fibrosis in Mice

Kazuya Koyama, Hisatsugu Goto, Shun Morizumi, +8

American Journal of Respiratory Cell and Molecular Biology

Antifibrotic TherapyInflammatory Lung DiseaseLung InflammationImmunologyPathology +15